Oxethazaine

Especificaciones

126-27-2Número CAS

204-780-5Número CE

2-[2-hydroxyethyl-[2-[methyl-(2-methyl-1-phenylpropan-2-yl)amino]-2-oxoethyl]amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamideNombre IUPAC

C28H41N3O3Fórmula química

467.6 g/molPeso molecular

Oxethazaine; 126-27-2; Oxetacaine; Oxethacaine; Oxaine; Muthesa; Strocain; Oxetacaina; oxethazine; Oxetacainum; Wy-806; WY 806; DTXSID0025818; Acetamide, 2,2'-((2-hydroxyethyl)imino)bis(N-(1,1-dimethyl-2-phenylethyl)-N-methyl-; FH 099; NSC-758444; Acetamide, 2,2'-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methyl-; IP8QT76V17; DTXCID605818; 2-Di(N-methyl-N-phenyl-tert-butyl-carbamoylmethyl)aminoethanol; N,N-Bis(N-methyl-N-phenyl-tert-butylacetamido)-beta-hydroxyethylamine; 2,2'-((2-Hydroxyethyl)imino)bis(N-(alpha,alpha-dimethylphenethyl)-N-methylacetamide); Acetamide, 2,2'-((2-hydroxyethyl)imino)bis(N-(alpha,alpha-dimethylphenethyl)-N-methyl-; N-(1,1-dimethyl-2-phenyl-ethyl)-2-[[2-[(1,1-dimethyl-2-phenyl-ethyl)-methyl-amino]-2-oxo-ethyl]-(2-hydroxyethyl)amino]-N-methyl-acetamide; N-(1,1-dimethyl-2-phenyl-ethyl)-2-((2-((1,1-dimethyl-2-phenyl-ethyl)-methyl-amino)-2-oxo-ethyl)-(2-hydroxyethyl)amino)-N-methyl-acetamide; RefChem:857129; C05AD06; 2,2'-((2-hydroxyethyl)imino)bis(N-alpha,alpha-dimethylphenethyl)-N-methylacetamide; 2,2'-(2-Hydroxyethylimino)bis(N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide); 204-780-5; oxetacain; Mucaine; Betalgil; Oxaethacainum; Oxetacaine [INN]; CHEMBL127592; 2-[2-hydroxyethyl-[2-[methyl-(2-methyl-1-phenylpropan-2-yl)amino]-2-oxoethyl]amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide; Oxetacaine (INN); MFCD00079202; NCGC00016382-01; CAS-126-27-2; 2,2'-((2-Hydroxyethyl)imino)bis(N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide); C28H41N3O3; Oxethacaina [Italian]; Milzine; Oxetacainum [INN-Latin]; Oxetacaina [INN-Spanish]; 2,2'-[(2-Hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide]; CCRIS 4692; SR-05000001851; EINECS 204-780-5; Oxethazaine [USAN:JAN]; BRN 2404063; UNII-IP8QT76V17; Prestwick_767; Oxethazaine (Standard); Spectrum_001657; OXETHAZAINE [MI]; Prestwick0_000058; Prestwick1_000058; Prestwick2_000058; Prestwick3_000058; Spectrum2_001987; Spectrum3_001751; Spectrum4_000202; Spectrum5_001269; OXETHAZAINE [JAN]; OXETHAZAINE [USAN]; cid_4621; OXETACAINE [MART.]; OXETACAINE [WHO-DD]; Oxethazaine (JP18/USAN); SCHEMBL24489; BSPBio_000215; BSPBio_003482; KBioGR_000803; KBioSS_002137; 4-12-00-02822 (Beilstein Handbook Reference); MLS002154188; DivK1c_000715; SPECTRUM1503279; SPBio_002136; SPBio_002173; BPBio1_000237; orb1226646; orb1310992; Oxethazaine, analytical standard; CHEBI:31947; HMS502D17; HY-B0955R; KBio1_000715; KBio2_002137; KBio2_004705; KBio2_007273; KBio3_002702; NINDS_000715; HMS1568K17; HMS1922A04; HMS2093C15; HMS2095K17; HMS2236A03; HMS3370M13; HMS3712K17; HMS3885P21; HMS5083A13; Pharmakon1600-01503279; HY-B0955; MSK10514; Tox21_110407; BDBM50017672; CCG-39525; EBC-27170; NSC758444; AKOS024284189; Tox21_110407_1; CS-4432; DB12532; FO26625; NSC 758444; IDI1_000715; NCGC00016382-02; NCGC00016382-03; NCGC00016382-04; NCGC00016382-07; NCGC00016382-09; NCGC00095039-01; NCGC00095039-02; NCGC00095039-03; 2-[(2-hydroxyethyl)({[methyl(2-methyl-1-phenylpropan-2-yl)carbamoyl]methyl})amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide; MS-28631; SMR001233479; ST073363; SY491470; SBI-0051816.P002; DB-041818; AB00052348; NS00010381; SW196906-3; T0044; D01152; G12282; AB00052348_08; AB00052348_09; EN300-26506802; Q2412605; SR-05000001851-1; SR-05000001851-3; BRD-K56940463-001-05-4; BRD-K56940463-001-08-8; BRD-K56940463-001-13-8; BRD-K56940463-001-14-6; 2-Di(N-methyl-N-phenyl-tert-butyl-carbamoylmethyl)amino ethanol; 2,2'-[(2-Hydroxyethyl)azanediyl]bis[N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide]; 2,2 inverted exclamation marka-[(2-Hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide]; 2,2'-((2-HYDROXYETHYL)IMINO)BIS(N-(.ALPHA.,.ALPHA.-DIMETHYLPHENETHYL)-N-METHYLACETAMIDE); N-(1,1-Dimethyl-2-phenyl-ethyl)-2-[{[(1,1-dimethyl-2-phenyl-ethyl)-methyl-carbamoyl]-methyl}-(2-hydroxy-ethyl)-amino]-N-methyl-acetamide; N-(1,1-dimethyl-2-phenylethyl)-2-({[N-(1,1-dimethyl-2-phenylethyl)-N-methylcar bamoyl]methyl}(2-hydroxyethyl)amino)-N-methylacetamide; Oxetacain (Oxethazin)Sinónimos